QB00 Stock Overview
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Biotricity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.18 |
| 52 Week High | US$2.55 |
| 52 Week Low | US$1.02 |
| Beta | 1.54 |
| 1 Month Change | -23.38% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -53.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| QB00 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -6.3% | -1.2% | 1.2% |
| 1Y | n/a | -25.9% | 2.0% |
Return vs Industry: Insufficient data to determine how QB00 performed against the German Healthcare Services industry.
Return vs Market: Insufficient data to determine how QB00 performed against the German Market.
Price Volatility
| QB00 volatility | |
|---|---|
| QB00 Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 3.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: QB00's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine QB00's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 55 | Waqaas Al-Siddiq | www.biotricity.com |
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.
Biotricity, Inc. Fundamentals Summary
| QB00 fundamental statistics | |
|---|---|
| Market cap | €11.31m |
| Earnings (TTM) | -€14.35m |
| Revenue (TTM) | €10.84m |
1.1x
P/S Ratio-0.8x
P/E RatioIs QB00 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QB00 income statement (TTM) | |
|---|---|
| Revenue | US$11.63m |
| Cost of Revenue | US$4.01m |
| Gross Profit | US$7.62m |
| Other Expenses | US$23.00m |
| Earnings | -US$15.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.62 |
| Gross Margin | 65.52% |
| Net Profit Margin | -132.33% |
| Debt/Equity Ratio | -82.6% |
How did QB00 perform over the long term?
See historical performance and comparison